Join Anju Mathew, OncoLens CEO, and Stacie Hansen, RN MSN NEA-BC, Service Line Leader, Ascension Lourdes Regional Cancer Center for a live webinar on Wednesday, October 21st @ 12:30pm ET.
Attendees will walk away from this 30-minute webinar with fresh ideas on:
Join Us for Our Webinar! Register Now:
New! The OncoLens software platform enables multidisciplinary discussion of cancer cases critical to the development of the right treatment plan for a patient. It replaces the labor-intensive process of aggregating relevant patient data along with the latest treatment options and available clinical trials to support the development of the best treatment decision for the patient. The platform drives standardization of discussions and engagement from multiple specialties such as oncology, surgery, pathology, and others. Before the pandemic, these discussions were held in person. OncoLens wanted to ensure that cancer care did not stop due to new social-distancing restrictions, so it expedited the release of an integrated, HIPAA compliant, virtual Tumor Board module and offered it at no cost to cancer centers for a limited period. As a result, care team members were able to use the software to securely review patient data together and formulate treatment plans while practicing social distancing.Mark Flickinger of BIP Capital
"Why Entrepreneurs Need Agility Now More Than Ever"
Cancer care cannot stop. OncoLens recently surveyed executives, physicians and administrators who were forced to quickly respond to the pandemic and find solutions to continue clinical practice and maintain patient care.
Click the graphic to download the insights gleaned from the survey. Learn from your peers about their current and greatest challenges, how they are tackling them and trends they believe are here to stay.
Care for cancer patients can't stop during COVID-19. Hear how two organizations immediately reacted to help these patients. Listen and learn from CEO of Susan G. Komen Greater Atlanta Cati Stone and Dr. Simpson. Click here to listen.
OncoLens is easy to use. Pathologists love it because it saves them a lot of time. The virtual tumor board is a great asset to the platform, not only because of COVID-19, but for anytime a physician cannot be physically present at tumor board and would like to attend.S. Lash Cancer Conference Coordinator
Community Cancer Center
We are very impressed with the speed at which our OncoLens Virtual Tumor Board was put together − 3 days − and the level of customer service provided. They’ve clearly thought of everything — the program is outstanding.E. Brown, MD, FACS, Breast Program Lead
Comprehensive Breast Care
The flexibility of where you can be to participate is a huge bonus for many providers. In fact, one of our providers said he may never have to attend another tumor board in person again!M. Hubert-Fiscus, Cancer Conference Director
Great Lakes Cancer Care